Activa CRO Expands Regional reach to Ecuador- Operations starting in June 2016

Activa CRO Expands Regional reach to Ecuador- Operations starting in June 2016

activa cro

May 30th, 2016

Buenos Aires, Argentina – Activa CRO, a regional full-service contract research organization, today announced the beginning of operations in Ecuador as from June 2016.

Activa is successfully growing in LATAM, adding Ecuador to our existing operations in 8 high quality data producing countries. With similar time zones, culture and language, as well as efficient regulatory timelines, Ecuador is rapidly becoming an important player in the clinical research field, noted Mario Boskis, CEO of Activa CRO

Activa´s footprint in Latin America is strategically expanding, allowing its multinational clients (sponsor´s as well as partner CRO´s ) to jointly manage clinical trials on a global basis.

With its strong regional regulatory and operational expertise, Activa CRO is now covering more than 90% of the clinical research market in Latin America, providing high quality clinical research services since 2003.

Combining a “Boutique” concept of personalized products and services, supported by a robust QA and Medical Monitoring system, the regional CRO remains as a leading service provider to the biotechnology, pharmaceutical and medical device industry.

Activa CRO is now actively working in areas of Oncology, Orphan Drugs, Neglected Diseases (Chagas) Rheumatology, Cardiovascular and First in Human and Pivotal  studies in Medical Devices

 

About Activa CRO

ActivaCro is a privately-owned, regional full-service Contract Research Organization (CRO) based in Buenos Aires, Argentina, with operations in Latin America, providing high quality clinical research services to the biotechnology, pharmaceutical and medical device industries.

 

This article was written by

MARIO BOSKIS-Activa CRO Welcome from Our Editor:

Welcome to the Activa CRO Blog. This blog gives our readers a chance to read intriguing and hopefully “insightful news” about the clinical trial environment, and also provides for us an opportunity to communicate and editorialize trending topics related to human research.

Our goal for this blog is to continue to grow until we can add a platform on which to share opinions with the pharmaceutical business community, so we can more effectively connect readers from all over the world, sharing ideas that we hope will engage helpful discussions on all aspects regarding Clinical Research.

If you wish to collaborate in our Blog, you are more than welcome to send your article in “word” format via mail to info@activa-cro.com to the attention of Editor Activa Blog.

Cheers.

MARIO BOSKIS, M.D; FACC
CEO, Founder